We report a patient who had an oat cell bronchogenic carcinoma in association with the syndrome of inappropriate antidiuresis. There was an unusually long interval between the onset of hyponatraemia and clinically evident malignant disease. Dynamic testing of vasopressin secretion showed preservation of baroregulated, but not osmoregulated, vasopressin release. Immunoreactive vasopressin was detected in pleural fluid, which co-eluted with synthetic vasopressin on gel chromatography.
Introduction
Bronchogenic carcinoma with the syndrome of inappropriate antidiuresis (SIAD) has been well documented (Schwartz et al., 1957; Amatruda et al., 1963; Padfield et al., 1976) . Evidence has been provided for ectopic arginine vasopressin (AVP) production from tumour tissue (George, Capen and Phillips, 1972) , but recently Robertson (1977) has suggested excessive AVP secretion from the neurohypophysis as an alternative mechanism.-The appearance of overt SIAD in patients with bronchogenic carcinoma usually heralds the terminal phase of the illness (Padfield et al., 1976) , although SIAD preceding clinical recognition of the tumour (Willis, 1980) has been reported. Our patient demonstrated a number of unusual features; a particularly long period of time between the discovery of hyponatraemia and eventual tumour detection, evidence of both ectopic and neurohypophysial AVP secretion, and the presence of AVP in the pleural fluid. Random plasma AVP levels, determined by radioimmunoassay (Baylis and Heath, 1977) , were markedly elevated. Therefore, inappropriate secretion of antidiuretic hormone was confirmed. Osmoregulation of vasopressin secretion was tested by water loading and hypertonic saline infusion. Following administration of a standard water load of 20 ml/kg, plasma AVP failed to suppress, urine osmolality remained high, free water clearance did not increase and by four hours, only 35% of the load had been excreted (Fig. 1) . The infusion of hypertonic (5%) saline at a rate of 0 06 ml/kg/min (Baylis and Robertson, 1980) was associated with fluctuations in vasopressin which bore no relationship to the rise in plasma osmolality from 257 to 271 mOsm/kg (Fig. 2) . Baroregulation of AVP secretion was tested by tilting the patient from the horizontal position to 85°tilt (Davies et al., 1976) . Following the tilt, there was a 30% fall in mean arterial blood pressure which caused a rise in plasma AVP of 15 fmol/ml (Fig. 3) . On the basis of the osmoregulatory studies, a diagnosis of ectopic AVP secretion from an unknown source was made.
Only 2 months later he was readmitted with extreme dyspnoea and signs of a large left-sided pleural effusion. Sputum cytology revealed malignant cells suggestive of an oat cell carcinoma. Similar cells were detected in the pleural aspirate. Immunoreactive AVP was demonstrated in the pleural fluid (17 fmol/ml). The elution profile of this material on Sephadex G-25 co-eluted with synthetic AVP (Fig.   4 ).
Death occurred one month later. Post-mortem examination confirmed an oat cell carcinoma of the bronchus with metastatic spread to the diaphragm, pancreas and left adrenal gland. There were no cerebral metastases.
Discussion
Mild hyponatraemia was first noted in this patient 4 years before his death. At that stage he had suffered a mild stroke and the hyponatraemia may have reflected non-specific ill-health resulting in the sickcell syndrome (Flear, Gill and Burn, 1981) (Fichman et al., 1971) . After withdrawal of the thiazide, hyponatraemia persisted, thus militating against this drug contributing significantly to his hyponatraemia. Although he drank moderate amounts of beer, we feel that beer drinker's hyponatraemia (Demanet et al., 1971 ) is a most unlikely cause for his hyponatraemia since he continued to eat a normal balanced diet, remained well-nourished, and drank no more than 15 pints of beer each week.
From mid-1979 he demonstrated a persistent, dilutional hyponatraemia which was well documented. Investigations in 1980 confirmed that he fulfilled the criteria of the syndrome of inappropriate antidiuretic hormone secretion (Bartter and Schwartz, 1967) . Studies on the osmoregulatory control of AVP secretion showed total loss of osmoregulation, with wide erratic fluctuations in plasma AVP during osmo-stimulatory (hypertonic saline infusion) and osmo-inhibitory (oral waterloading) tests. This pattern of response accounts for approximately 35% of all patients with SIAD and may reflect either ectopic hormone production from tumour tissue or erratic production from the posterior pituitary (Zerbe, Stropes and Robertson, 1980 (Robertson, 1977) . The source of the tumour-derived AVP was not apparent until 1981, although in the later part of the previous year the chest X-ray was abnormal.
In 1981, the patient's health deteriorated rapidly, with increasing dyspnoea due to a large pleural effusion. Immunoreactive AVP, not reported previously in pleural fluid, was detected at concentrations similar to plasma values. To check that there was no non-specific interference in the immunoassay, an aliquot of pleural fluid was fractionated on Sephadex G-25, and the material in the fluid co-eluted with synthetic AVP, thus adding considerable evidence that the material in the pleural fluid was AVP. Whether this AVP was a transudate from blood, in which AVP circulates unbound to plasma proteins (Share and Crofton, 1980) , or was an exudate from the tumour, remains unclear.
In conclusion, we believe that this patient had SIAD from ectopic production of AVP from an oat cell bronchogenic carcinoma, which was first manifest at least 2 years, and possibly 4 years, before the tumour was evident. This period is considerably longer than the 7 months reported by Willis (1980) and 3 months by Padfield et al. (1976) . Baroregulation of AVP secretion was retained, but osmotic control was lost. AVP was detected in the pleural fluid.
